Compound 219
Identifiers
- Canonical SMILES:
CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCC1CCCCC1
- IUPAC name:
(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(cyclohexylmethyl)pyrrolidine-2-carboxamide
- InChi:
InChI=1S/C20H36N4O3/c1-13(2)17(23-18(25)14(3)21)20(27)24-11-7-10-16(24)19(26)22-12-15-8-5-4-6-9-15/h13-17H,4-12,21H2,1-3H3,(H,22,26)(H,23,25)/t14-,16-,17-/m0/s1
- InChiKey:
UETWNTWJPLMFAF-XIRDDKMYSA-N
External links
11176463 |
CHEMBL359812 |
9351555 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 5.90 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 380.28 g/mol | |||
HBA | 7 | |||
HBD | 4 | |||
HBA + HBD | 11 | |||
AlogP | 1.04 | |||
TPSA | 104.53 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8628 | Cyclo(prolylglycyl) | DB04541 | |
0.8628 | acetylleucyl-leucyl-norleucinal | DB07558 | |
0.7736 | Brivaracetam | DB05541 | |
0.7460 | NNZ-2591 | DB15601 | |
0.7400 | Valrocemide | DB06657 | |
0.7302 | Rapastinel | DB11801 | |
0.7302 | Dusquetide | DB11879 | |
0.7213 | 3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE | DB08323 | |
0.7188 | Larazotide | DB05645 | |
0.7188 | Sinapultide | DB11332 | |
0.7115 | PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE | DB08421 | |
0.7115 | Pramiracetam | DB13247 | |
0.7059 | 3-AMINO-AZACYCLOTRIDECAN-2-ONE | DB08476 | |
0.7031 | Verpacamide A | DB04433 | |
0.6875 | N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine | DB02578 |